History of antiangiogenic drugs in multiple myeloma, starting with thalidomide

Bookmark and Share
Published: 2 Nov 2016
Views: 2117
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany

Dr Hillengaß talks to ecancertv at ICMM 2016 about the history of thalidomide as a treatment for multiple myeloma and the subsequent treatments this led to such as lenalidomide and pomalidomide in combination with dexamethasone.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content